PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.40%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-5.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-6.02%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-6.02%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-9.09%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-13.33%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-13.33%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
4.90%
Share change of 4.90% while UPM.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
4.90%
Diluted share change of 4.90% while UPM.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
2.90%
OCF growth under 50% of UPM.HE's 133.97%. Michael Burry might suspect questionable revenue recognition or rising costs.
-9.50%
Negative FCF growth while UPM.HE is at 560.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-36.02%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-12.26%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-2.71%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
377.72%
10Y OCF/share CAGR above 1.5x UPM.HE's 8.49%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-25.47%
Negative 5Y OCF/share CAGR while UPM.HE is at 0.59%. Joel Greenblatt would question the firm’s operational model or cost structure.
8.92%
Positive 3Y OCF/share CAGR while UPM.HE is negative. John Neff might see a big short-term edge in operational efficiency.
11.18%
Positive 10Y CAGR while UPM.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
62.50%
Positive 5Y CAGR while UPM.HE is negative. John Neff might view this as a strong mid-term relative advantage.
18.18%
Positive short-term CAGR while UPM.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
17.24%
10Y equity/share CAGR at 50-75% of UPM.HE's 31.77%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
19.67%
5Y equity/share CAGR 1.25-1.5x UPM.HE's 17.81%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
16.32%
3Y equity/share CAGR 1.25-1.5x UPM.HE's 12.32%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.37%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.47%
Positive asset growth while UPM.HE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-1.54%
We have a declining book value while UPM.HE shows 0.23%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.15%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-7.45%
We cut SG&A while UPM.HE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.